2026 ICD-10-CM Diagnosis Code C96.29Other malignant mast cell neoplasm
ICD-10-CM Codes›C00–D49›C81-C96›C96
- Billable — Valid for Submission
- Chronic Condition
C96.29 is a billable ICD-10-CM diagnosis code for other malignant mast cell neoplasm. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Non-Hodgkin lymphoma.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Malignant mast cell sarcoma of spleen
- Malignant mast cell tumor of intra-abdominal lymph nodes
- Malignant mast cell tumor of intrapelvic lymph nodes
- Malignant mast cell tumor of intrathoracic lymph nodes
- Malignant mastocytosis
- Mast cell malignancy of lymph nodes
- Mast cell malignancy of lymph nodes of head and neck
- Mast cell malignancy of lymph nodes of multiple sites
- Systemic mast cell disease
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- neoplasm
- specified type NEC - C96.29
- Mastocytoma (extracutaneous) - D47.09
- malignant - C96.29
- Mastocytosis - D47.09
- malignant - C96.29
- Neoplasm, neoplastic - See Also: Table of Neoplasms;
- malignant mast cell - C96.20
- specified type NEC - C96.29
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Mast cell
- neoplasm
- malignant
- specified type NEC
- Mastocytoma(extracutaneous)
- malignant
- Mastocytosis
- malignant
- Neoplasm, neoplastic
- malignant mast cell
- specified type NEC
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Convert C96.29 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code History & ChangesHistory
Replacement C96.29 replaces the following previously assigned code(s):
- C96.2 - Malignant mast cell neoplasm
- C96.2 - Malignant mast cell tumor
Questions About C96.29Overview
Is C96.29 (Malignant mast cell neoplasm) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other malignant mast cell neoplasm on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C96.29 group to?
When other malignant mast cell neoplasm is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, with relative weights from 1.0104 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C96.29?
Under the General Equivalence Mappings, other malignant mast cell neoplasm converts to ICD-9-CM 202.60 (mlg mast unsp xtrndl org), 202.61 (mal mastocytosis head), and 202.62 (mal mastocytosis thorax). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
